30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Donegan Michael C

Insider profile

Performance

Overall performance
4.0

Performance over holding periods
4.0
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 77% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Donegan Michael C's trades of TherapeuticsMD Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2023-01-30 2023-01-27 S Sale
5,906 -36.5%
442.47
US$2,240,561
5,906 -36.5% 442.47 US$2,240,561
2023-01-30 2023-01-26 S Sale
67,680 -11.7%
197.11
US$28,343
67,680 -11.7% 197.11 US$28,343
2023-01-25 2023-01-24 S Sale
69,180 +25.1%
92.21
US$2,882,975
69,180 +25.1% 92.21 US$2,882,975
2023-01-25 2023-01-23 S Sale
1,302 -14.6%
5.34
US$6,950
1,302 -14.6% 5.34 US$6,950
2022-12-09 2022-12-06 S Sale
910 -16.7%
4.78
US$4,345
910 -16.7% 4.78 US$4,345
2021-12-02 2021-11-30 S Sale
29,790 -23.1%
0.54
US$15,947
29,790 -23.1% 0.54 US$15,947
2021-05-12 2021-05-11 S Sale
4,842 -25.5%
1.04
US$5,036
4,842 -25.5% 1.04 US$5,036